Cargando…

Upregulation of Coxsackie Adenovirus Receptor Sensitizes Cisplatin-Resistant Lung Cancer Cells to CRAd-Induced Inhibition

Objective. Conditionally replicating adenoviruses (CRAds) have been proven potent oncolytic viruses in previous studies. They selectively replicate in the tumor cells because of incorporated survivin promoter and ultimately lead to their killing with minimal side effects on normal tissue. Chemothera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sakhawat, Ali, Liu, Yanan, Ma, Ling, Muhammad, Tahir, Wang, Shensen, Zhang, Lina, Cong, Xianling, Huang, Yinghui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5479248/ https://www.ncbi.nlm.nih.gov/pubmed/28638457 http://dx.doi.org/10.7150/jca.18371

Ejemplares similares

Cisplatin Synergistically Enhances Antitumor Potency of Conditionally Replicating Adenovirus via p53 Dependent or Independent Pathways in Human Lung Carcinoma
por: Ali, Sakhawat, et al.
Publicado: (2019)

Defining a murine ovarian cancer model for the evaluation of conditionally-replicative adenovirus (CRAd) virotherapy agents
por: González-Pastor, Rebeca, et al.
Publicado: (2019)

Combinatorial strategies based on CRAd-IL24 and CRAd-ING4 virotherapy with anti-angiogenesis treatment for ovarian cancer
por: Ashshi, Ahmad Mohammad, et al.
Publicado: (2016)

Loss of the coxsackie and adenovirus receptor contributes to gastric cancer progression
por: Anders, M, et al.
Publicado: (2009)

Loss of Coxsackie and adenovirus receptor downregulates α-catenin expression
por: Stecker, K, et al.
Publicado: (2009)

A tumor targeting oncolytic adenovirus can improve therapeutic outcomes in chemotherapy resistant metastatic human breast carcinoma
por: Sakhawat, Ali, et al.
Publicado: (2019)

Protective Role of Coxsackie-Adenovirus Receptor in the Pathogenesis of Inflammatory Bowel Diseases
por: Chen, Xiong, et al.
Publicado: (2018)

Mesenchymal stem cells as carriers and amplifiers in CRAd delivery to tumors
por: Xia, Xi, et al.
Publicado: (2011)

A novel monoclonal antibody targeting coxsackie virus and adenovirus receptor inhibits tumor growth in vivo
por: Kawada, Manabu, et al.
Publicado: (2017)

Study of Coxsackie B viruses interactions with Coxsackie Adenovirus receptor and Decay-Accelerating Factor using Human CaCo-2 cell line
por: Riabi, Samira, et al.
Publicado: (2014)

Essential Role of the Coxsackie - and Adenovirus Receptor (CAR) in Development of the Lymphatic System in Mice
por: Mirza, Momina, et al.
Publicado: (2012)

Isoform-Specific Regulation and Localization of the Coxsackie and Adenovirus Receptor in Human Airway Epithelia
por: Excoffon, Katherine J. D. A., et al.
Publicado: (2010)

Characterization of a novel OX40 ligand and CD40 ligand-expressing oncolytic adenovirus used in the PeptiCRAd cancer vaccine platform
por: Ylösmäki, Erkko, et al.
Publicado: (2021)

Human Adenovirus 52 Uses Sialic Acid-containing Glycoproteins and the Coxsackie and Adenovirus Receptor for Binding to Target Cells
por: Lenman, Annasara, et al.
Publicado: (2015)

Single dose GLP toxicity and biodistribution study of a conditionally replicative adenovirus vector, CRAd-S-pk7, administered by intracerebral injection to Syrian hamsters
por: Kim, Julius Woongki, et al.
Publicado: (2016)

ZEB1 limits adenoviral infectability by transcriptionally repressing the Coxsackie virus and Adenovirus Receptor
por: Lacher, Markus D, et al.
Publicado: (2011)

Coxsackie–adenovirus receptor expression is enhanced in pancreas from patients with type 1 diabetes
por: Hodik, M, et al.
Publicado: (2016)

Human Coxsackie- and adenovirus receptor is a putative target of neutrophil elastase-mediated shedding
por: Herrmann, Leonie, et al.
Publicado: (2022)

Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1
por: Carlisle, Robert C., et al.
Publicado: (2009)

Efficient adenovirus-mediated gene transfer into primary T cells and thymocytes in a new coxsackie/adenovirus receptor transgenic model
por: Hurez, Vincent, et al.
Publicado: (2002)

Isoform-specific expression of the Coxsackie and adenovirus receptor (CAR) in neuromuscular junction and cardiac intercalated discs
por: Shaw, Christian A, et al.
Publicado: (2004)

Expression of coxsackie and adenovirus receptor distinguishes transitional cancer states in therapy-induced cellular senescence
por: Wu, P C, et al.
Publicado: (2010)

Transcription Factor Sp1 Is Involved in Expressional Regulation of Coxsackie and Adenovirus Receptor in Cancer Cells
por: Chung, Sun-Ku, et al.
Publicado: (2011)

Knockdown of CRAD suppresses the growth and promotes the apoptosis of human lung cancer cells via Claudin 4
por: Cui, Anfang, et al.
Publicado: (2020)

ERK1/2 pathway regulates coxsackie and adenovirus receptor expression in mouse cardiac stem cells
por: Liu, Jingjin, et al.
Publicado: (2017)

Extracellular Vesicles-Mimetic Encapsulation Improves Oncolytic Viro-Immunotherapy in Tumors With Low Coxsackie and Adenovirus Receptor
por: Zhang, Yonghui, et al.
Publicado: (2020)

IRES-Mediated Protein Translation Overcomes Suppression by the p14ARF Tumor Suppressor Protein
por: Xi, Song, et al.
Publicado: (2017)

Loss of coxsackie and adenovirus receptor expression in human colorectal cancer: A potential impact on the efficacy of adenovirus-mediated gene therapy in Chinese Han population
por: Ma, Ying-Yu, et al.
Publicado: (2016)

COVID-19-related autoimmune disorders of central nervous system (CRAD-C): Is it a new entity?
por: Naser Moghadasi, Abdorreza
Publicado: (2021)

Unexpected subcellular distribution of a specific isoform of the Coxsackie and adenovirus receptor, CAR-SIV, in human pancreatic beta cells
por: Ifie, Eseoghene, et al.
Publicado: (2018)

Marine Lectins DlFBL and HddSBL Fused with Soluble Coxsackie-Adenovirus Receptor Facilitate Adenovirus Infection in Cancer Cells BUT Have Different Effects on Cell Survival
por: Wu, Bingbing, et al.
Publicado: (2017)

Coxsackie Virus Infections in Southern Africa
por: Gear, James
Publicado: (1961)

NEUROPATHOGENICITY OF GROUP A COXSACKIE VIRUSES
por: Dalldorf, Gilbert
Publicado: (1957)

Home-based intensive treatment of chronic radiation-associated dysphagia in head and neck cancer survivors (HIT-CRAD trial)
por: Massonet, Hanne, et al.
Publicado: (2022)

AGE AND SUSCEPTIBILITY OF MICE TO COXSACKIE A VIRUSES
por: Lerner, A. Martin, et al.
Publicado: (1962)

SUSCEPTIBILITY OF GRAVID MICE TO COXSACKIE VIRUS INFECTION
por: Dalldorf, Gilbert, et al.
Publicado: (1954)

Coxsackie encephalitis in a child in Western India
por: Shah, Ira, et al.
Publicado: (2017)

Mesenchymal stem cell-mediated delivery of therapeutic adenoviral vectors to prostate cancer
por: Muhammad, Tahir, et al.
Publicado: (2019)

Mycophenolate mofetil inhibits the development of Coxsackie B3-virus-induced myocarditis in mice
por: Padalko, Elizaveta, et al.
Publicado: (2003)

Histone Deacetylase Inhibitors Restore Cell Surface Expression of the Coxsackie Adenovirus Receptor and Enhance CMV Promoter Activity in Castration-Resistant Prostate Cancer Cells
por: Kasman, Laura, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_dlpqi94r0n7nbk1c50s57asv3i